DPP4 and malignant colon neoplasm: Although 5FU treatment enriched a subpopulation of CD26+ cells, which enhanced the migratory and invasive ability of colon cancer, combination treatment with Raf265 reversed the 5FU effect by targeting on the CD26+ cells and in vivo study demonstrated a significant inhibition of liver and lung metastasis.